4 medicines held by Amgen Technology (Ireland) UC on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| WEZENLA 130 mg Concentrate for solution for infusion EU/1/24/1823/004 |
Ustekinumab | Amgen Technology (Ireland) UC | — |
| WEZENLA 45 mg Solution for injection EU/1/24/1823/001 |
Ustekinumab | Amgen Technology (Ireland) UC | — |
| WEZENLA 45 mg Solution for injection pre-filled syringe EU/1/24/1823/002 |
Ustekinumab | Amgen Technology (Ireland) UC | — |
| WEZENLA 90 mg Solution for injection pre-filled syringe EU/1/24/1823/003 |
Ustekinumab | Amgen Technology (Ireland) UC | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.